Drugs for Neglected Diseasesinitiative North America Inc

Analysis

Drugs for Neglected Diseasesinitiative North America Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in November 2007, 19 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Drugs for Neglected Diseasesinitiative North America Inc reported income of $4.4m and spending of $4.2m, spending 96% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $4.6m to $4.4m (-6.0%), an average of -1.5% a year. The sharpest change came in the year to December 2020, when income dropped by 19%. Over the whole period it spent 97% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Drugs for Neglected Diseasesinitiative North America Inc sits at the 78th percentile: it is larger than about 78% of them. Against every charity in United States with reported income it ranks in the 91st percentile, and in the 89th percentile within NY. Charities of a similar size with the same main cause include Northbay Health Advantage ($4.4m), Greensboro Hospital Association Inc ($4.4m) and Bethel Family Clinic ($4.3m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $275k (6.6% of expenses). Other salaries and wages came to $959k. At year end it held assets of $1.8m against liabilities of $715k, net assets of $1.1m. It reported 10 employees.